Question 1 of 3
Are you (18+) or your child (2-4 or 12-17 years old) immunocompromised due to an underlying medical condition or treatment for an underlying medical condition?
Question 2 of 3
Have you or your child been previously diagnosed with COVID-19?
Question 3 of 3
Have you or your child previously received a COVID-19 vaccine?

So far - So good!

You appear to meet the basic requirements for this COVID-19 Vaccine study. Please enter your information below to find a study location near you. Once you select a site, the research study staff will contact you to see if you qualify to enroll.

Choose a Location
See below to select a research site near you. If you don't see a site near you, then select "The sites listed here are not convenient for me." and a study representative will call you if a research site becomes available in your area.

Henry Ford Cancer Institute

2799 W. Grand Blvd.
Detroit, MI 48202
NaN Mi

Oshsner Clinic Foundation

1514 Jefferson Hwy LT7S
New Orleans, LA 70121
NaN Mi

The sites listed here are not convenient for me.

Sorry, you are not eligible at this time...

Thank you so much for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

First name must not be blank

Last name must not be blank

Please enter a valid phone number

Please enter a valid email

Please select a valid address

About The COVID-19 Vaccine Study for Immunocompromised Patients

Every modern vaccine and medicine we have today was first studied in clinical trials involving hundreds to thousands of people before becoming available to the public. Previous clinical trials involving this COVID-19 vaccine were not designed to include most patients with compromised immune systems. This trial will help determine how safe and tolerable the COVID-19 study vaccine is for individuals with compromised immune systems, and how well their immune systems respond to the vaccine.

By choosing to volunteer, you will represent people like you with conditions that make them immunocompromised.

Who Can Participate

  • Adults at least 18 years of age who have been diagnosed with one of the following:
    • Non-Small Cell Lung Cancer
    • Chronic Lymphocytic Leukemia
    • End-Stage Renal Disease on hemodialysis
    • Receiving immunomodulators therapy for an autoimmune inflammatory disorder
  • Children 2-4 and adolescents 12-17 years of age for which one of the following is true:
    • Receiving immunomodulators therapy for an autoimmune inflammatory disorder
    • Are receiving maintenance antirejection medications for an organ transplant
    • Have undergone a bone marrow or stem cell transplant
  • Participants should not have been previously diagnosed with COVID-19
  • Participants should not have already received a COVID-19 vaccine

Note: These are not the only eligibility criteria for this clinical research study. A clinical research team member will help determine if this study is right for your child based on all of the participation criteria.

The number of participants for the 5-11 year -old age group has been reached and is no longer enrolling new participants

top of section

What To Expect


All participants will receive the COVID-19 study vaccine. You or your child will receive 3 doses over the course of 6-7 months. Doses will be given as an injection in the upper arm. The first 2 injections will be given about 3 weeks apart at the start of study. A third injection will be given at a later date.


All participants will have at least 7 scheduled visits at the study site and will be a part of the study for about 14 months.


All participants will be asked to track any symptoms or side effects in an electronic diary (e-diary).


All participants will be paid a stipend per visit to serve as reimbursement for their expenses (such as parking, meals, travel) and time related to completing the e-diary.

bottom of section
Pfizer Logo
BioNTech Logo